PackTalk is a blog for the Healthcare Packaging Industry

The FDA Authorizes First COVID-19 Saliva-Based Test for Home


Published on May 20, 2020

With COVID-19 test kits in high demand, the FDA has been authorizing new at-home sample collections to help make tests more accessible.

Until this point, all at-home tests have required collection from a patient’s nose using a nasal swab and saline. But, earlier in May, the FDA approved the first COVID-19 saliva-based at home collection test by Rutgers Clinical Genomics Laboratory. This prescription-only test allows patients to collect their own sample, easily and safely, without requiring a trip to the doctor’s office.

Saliva-based testing has been found to be just as accurate, if not more so, than nasal testing and the sample is easier, safer and more comfortable to attain.

Learn more about this at home test kit here.


Comments (0)

Related Articles

What Does a Packaging Engineer Do?

May 27, 2023

It's often said that "everything you see comes in a package." But have you ever stopped to think about what goes into creating that package? Or even WHO? Behind every great package is a packaging engineer—a niche profession. Those who are familiar with what a...

Learn More

An All Access Student Pass to the[PACK]out

May 27, 2023

Last week, I had the opportunity to attend the[PACK]out with the support and sponsorship of Oliver Healthcare Packaging. the[PACK]out is a healthcare packaging conference focused on providing industry professionals the opportunity to connect, collaborate, and...

Learn More

Investing in Europe

May 27, 2023

The Covid-19 pandemic exposed severe weaknesses in the global supply chain for medical device packaging. As a result, Oliver is committed to investing in regionalizing our supply chain. Recently, Oliver CEO, Mike Benevento, sat down with Medical Device...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.